BACKGROUND. Black individuals have lower natriuretic peptide levels and greater risk of heart failure (HF) than white individuals. Higher N-terminal-pro-B-type natriuretic peptide (NT-proBNP) is associated with increased risk of incident HF, but little information is available in black individuals. We examined race-specific differences in 1) the association of NT-proBNP with incident HF and 2) the predictive ability of NT-proBNP for incident HF across body mass index (BMI) and estimated glomerular filtration rate (eGFR) categories.
Introduction
Natriuretic peptides (NPs) are hormones produced by the heart.(1) Hemodynamic challenges such as pressure overload seen in hypertension and volume overload seen in heart failure (HF) are associated with higher circulating NP levels. (2, 3) The role of NPs in the diagnosis and prognosis of HF has been well established.(4-6) Additionally, population-based studies have concluded that NPs can predict the risk of cardiovascular disease including incident HF. (7) (8) (9) However, the information on racial differences in the relationship between N-terminalpro B-Type NP (NT-proBNP) levels and incident HF is small. Study of racial differences in magnitude of association of NP levels with incident HF is of particular relevance since we and others recently described that black individuals have significantly lower NP levels as compared with white individuals. (10) (11) (12) (13) In addition to race, increasing age, sex, obesity, and impaired renal function affect circulating NP levels. (14) (15) (16) (17) (18) Prior studies have reported that the association between NP levels and incident HF differed by body mass index (BMI) (19) and estimated glomerular filtration rate (eGFR) categories. (20) However, little is known about the relationship of NP levels and incident HF across BMI and eGFR categories among black individuals, a key racial group at risk for HF.
The REasons for Geographic And Racial Differences in Stroke (REGARDS) study offers a unique opportunity to examine race-specific risk associated with NT-proBNP for incident HF, including in subgroups who are obese or with impaired renal function in a large, bi-racial population of the United States adults.
We aimed to examine 1) the differences in the relationship of NT-proBNP levels and incident HF by race, and 2) whether the risk of incident HF predicted by NT-proBNP levels across BMI and eGFR categories differed by race.
Results

Study Participants
Of the 4,415 randomly selected participants, we excluded individuals with missing NTproBNP (n=254), suspect or missing information on HF status (n=598), missing or BMI less than 18.5 kg/m 2 (n=70) (i.e., due to fewer participants and possible confounding with other BMI categories). We additionally excluded individuals with missing information of other covariates (n=446) (Figure 1 ). There were 124 incident HF cases identified among randomly selected participants. After applying similar exclusion criteria, we excluded 249 individuals from the 812 incident HF cases (Figure 1 ). These exclusions resulted in including 687 cases of incident HF during follow-up and 2,923 participants in the cohort random sample in the study (Figure 1 ). 
NT-proBNP Levels and Incident Heart Failure
The risk of HF rose sharply across tertiles of baseline NT-proBNP (Table 2) . Table 3) .
NT-proBNP Levels and Incident Heart Failure by BMI and eGFR Categories
Among white participants, the risk of HF per doubling of NT-proBNP was similar across BMI and eGFR categories (Pinteraction >0.1) ( Harrell's C-statistic.
Discussion
In this population-based study of REGARDS participants, higher NT-proBNP was strongly associated with incident HF independent of sociodemographic and clinical risk factors.
The magnitude of the relationship of NT-proBNP levels with incident HF was greater in white individuals than black individuals ( Figure 5) . Further, the magnitude of association between NT-proBNP and incident HF was preserved across BMI and eGFR categories among white (7) Ours is the first study to report a significant interaction by race in the association of NT-proBNP levels with incident HF. This may be due to the fact that our study is a case-cohort study design and included a large proportion of black individuals.
Additionally, the difference between our findings compared with other cohorts could be due to the changing paradigm of cardiovascular disease risk factors (i.e., decreasing prevalence of ischemic heart disease and increasing prevalence of hypertension and diabetes). This further underscores the significance of assessing the relationship of NT-proBNP with incident HF by race in contemporary cohorts such as REGARDS. A recent population-based study has suggested that black race is associated with lower lifetime risk in development of HFpEF but not with HFrEF as compared with other races.(23) However, we did not observe any modification in the relationship between NT-proBNP and incident HF sub-groups by race, which may be due to limited power to detect this interaction.
Population-based studies have suggested that obese individuals have lower circulating NP levels as compared with lean individuals, (24, 25) while impaired renal function is associated with higher circulating NP levels. (26, 27) The association between circulating NP levels and incident HF differed by BMI (19) and renal function categories (20) in other studies. However, none of the prior studies (19, 20) have observed that the association between NP levels and incident HF across BMI and eGFR categories differed by race. Investigators from the ARIC study (19) observed a blunting in the relationship of NT-proBNP levels with incident HF among individuals with obesity as compared with individuals with normal weight in overall population. Similar to the ARIC study, (19) we observed an attenuation in the association between NT-proBNP levels and incident HF. However, this attenuation was only observed among black individuals but not in white individuals in our cohort. The differences between our findings and those of the ARIC study (19) Our findings suggest that to improve the accuracy of risk prediction models using NT-proBNP levels for incident HF, we need to account for other factors that can affect NP levels, such as race, BMI, and eGFR, may be warranted.
Limitations
There are some limitations of our study. Prior studies have shown that NP levels have genetic basis.(11,13) Self-reported characterization of race was used instead of genetic ancestry information markers in this study. The results of the current study cannot be generalized to other racial or ethnic groups as the REGARDS study only included non-Hispanic white and black individuals. We used medication-based criteria to identify the presence of suspected HF at baseline instead of clinical diagnosis, which likely overestimated the prevalence of baseline HF.
Residual confounding due to unmeasured confounders is always possible, in spite of our inclusion of many of the factors that are known to affect NP levels. Finally, we used baseline NT-proBNP levels rather than serial measurements, which precludes study of race-specific trajectories of NT-proBNP in relation to incident HF.
Conclusions
In conclusion, we confirmed that NT-proBNP levels are associated with incident HF in a large biracial population-based study. The relationship of NT-proBNP levels with incident HF differed by race, showing a greater magnitude among white than black individuals. The risk of HF predicted by NT-proBNP levels was preserved across BMI and eGFR categories among white individuals. However, the predictive ability of NT-proBNP for incident HF was diminished with obesity and impaired renal function among black individuals. Besides age, important factors such as race, BMI, and eGFR should be considered while assessing and interpreting risk prediction models using NT-proBNP levels for incident HF.
Methods
Study Population
The REGARDS study was designed to investigate racial and geographic differences in stroke mortality. ( The primary exposure in this study was plasma NT-proBNP level. As described previously, NT-proBNP measurement was performed using an automated electrochemiluminescence immunoassay (Roche Elecsys 2010) inbaseline plasma samples. (10) The intra-and inter-assay coefficients of variation were less than 2% and 5%, respectively.
Outcome of Interest
The outcome of interest was incident HF hospitalization. Study participants were followed up every 6 months via telephone to detect hospitalizations.(37) Each suspected heart disease hospitalization was adjudicated by two clinicians by assessing medical records. (37, 38) Any disagreement between two adjudicators was resolved by discussion among the team were randomly selected to fulfill the desired distribution: 50% black, 50% white, 50% female, 50% male, 20% age 45-54, 20% age 55-64, 25% age 65-74, 25% age 75-84, and 10% age ≥85.
For the purpose of this analysis we excluded individuals with prevalent HF in the cohort random sample.
Covariates of Interest
Baseline characteristics such as age, sex, race, smoking status, alcohol use, and exercise were self-reported. BMI was measured during the in-home visit as weight in kilograms divided by height in meters squared. We divided the study participants into lean (i.e., BMI ≥18.5 to <25 kg/m 2 ), overweight (i.e., BMI ≥25 to <30 kg/m 2 ) and obese (i.e., BMI ≥30 kg/m 2 ) categories.
The average of two blood pressure measurements taken 5 minutes apart was used to assess systolic blood pressure. Hypertension was considered present if systolic blood pressure was ≥140 mm Hg, diastolic blood pressure was ≥90 mm Hg, or if the participant reported current use of anti-hypertensive medication. Aspirin use was self-reported. Diabetes was defined as selfreported current use of oral diabetes medications or insulin, or fasting glucose ≥126 mg/dl (or non-fasting glucose ≥200 mg/dl among those who did not fast). Dyslipidemia was defined as total cholesterol ≥240 mg/dl, low-density lipoprotein cholesterol ≥160 mg/dl, high-density 
Statistical Analyses
Statistical analyses were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC).
Within the cohort random sample, baseline characteristics were calculated using weights to account for the stratified sampling design by tertiles of NT-proBNP.
Cox proportional hazards models for case-cohort studies were used to estimate the association of NT-proBNP (modeled as a continuous variable and in tertiles) with incident HF. (40) For the continuous models, we employed log base 2-transformed NT-proBNP in order to calculate the hazard ratio (HR) for incident HF per doubling of NT-proBNP level. In the analyses with NT-proBNP modeled in tertiles, participants with the lowest tertile were chosen as a reference group. We constructed unadjusted models; followed by age, race, and sex-adjusted models; and then multivariable-adjusted models to assess the relationship of NT-proBNP with incident HF. The covariates included in the multivariable models were selected based on previous studies demonstrating their association with NT-proBNP levels: (10) (11) (12) (13) (47) (48) (49) age, race, sex, nSES, tobacco usage, physical activity, alcohol use, BMI, systolic blood pressure, use of antihypertensive medications, aspirin use, dyslipidemia, diabetes mellitus, history of stroke or transient ischemic attack, atrial fibrillation, peripheral vascular disease, history of coronary artery disease, left ventricular hypertrophy, and eGFR. In the multivariable models using NT-proBNP levels as a continuous variable, we further examined for effect modification by race by using a multiplicative interaction term (i.e., race * log2 NT-proBNP).
The relationship between log2 NT-proBNP and incident HF across BMI and eGFR categories by race were also examined using multivariable Cox proportional hazard models. The following covariates were included in the multivariable models: age, sex, nSES, lifestyle habits 
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